Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.
Year: 1987
Type: article
Source: PubMed
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: recombinant human interleukin-2, metastatic disease, lymphokine-activated killer cells, dose-response relationship, immunomodulation, pharmacokinetics, bioavailability, intraperitoneal administration, spontaneous metastasis, experimental metastasis, nude mice, T cell immunity, immunotherapy
Open Access status: closed
OpenAlex ID: W1593923919
